Literature DB >> 16857342

The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling.

Pascale G Charest1, Geneviève Oligny-Longpré, Hélène Bonin, Mounia Azzi, Michel Bouvier.   

Abstract

The V2 vasopressin receptor (V2R) activates the mitogen activated protein kinases (MAPK) ERK1/2 through a mechanism involving the scaffolding protein beta arrestin. Here we report that this activating pathway is independent of G alpha s, G alpha i, G alpha q or G betagamma and that the V2R-mediated activation of G alpha s inhibits ERK1/2 activity in a cAMP/PKA-dependent manner. In the HEK293 cells studied, the beta arrestin-promoted activation was found to dominate over the PKA-mediated inhibition of the pathway, leading to a strong vasopressin-stimulated ERK1/2 activation. Despite the strong MAPK activation and in contrast with other GPCR, V2R did not induce any significant increase in DNA synthesis, consistent with the notion that the stable interaction between V2R and beta arrestin prevents signal propagation to the nucleus. Beta arrestin was found to be essential for the ERK1/2 activation, indicating that the recruitment of the scaffolding protein is necessary and sufficient to initiate the signal in the absence of any other stimulatory cues. Based on the use of selective pharmacological inhibitors, dominant negative mutants and siRNA, we conclude that the beta arrestin-dependent activation of ERK1/2 by the V2R involves c-Src and a metalloproteinase-dependent trans-activation event. These findings demonstrate that beta arrestin is a genuine signalling initiator that can, on its own, engage a MAPK activation machinery upon stimulation of a GPCR by its natural ligand.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16857342     DOI: 10.1016/j.cellsig.2006.05.020

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  26 in total

1.  Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation.

Authors:  Geneviève Oligny-Longpré; Maithé Corbani; Joris Zhou; Mireille Hogue; Gilles Guillon; Michel Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

2.  Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.

Authors:  Yuan Liao; Bin Lu; Qiang Ma; Gang Wu; Xiangru Lai; Jiashu Zang; Ying Shi; Dongxiang Liu; Feng Han; Naiming Zhou
Journal:  J Biol Chem       Date:  2016-02-10       Impact factor: 5.157

Review 3.  Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction.

Authors:  K Defea
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 4.  Minireview: physiological and pathological actions of RAS in the ovary.

Authors:  Heng-Yu Fan; Joanne S Richards
Journal:  Mol Endocrinol       Date:  2009-10-30

5.  Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gβγ complex.

Authors:  Vanessa L Wehbi; Hilary P Stevenson; Timothy N Feinstein; Guillermo Calero; Guillermo Romero; Jean-Pierre Vilardaga
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

6.  5-hydroxytryptamine 4 receptor activation of the extracellular signal-regulated kinase pathway depends on Src activation but not on G protein or beta-arrestin signaling.

Authors:  Gaël Barthet; Bérénice Framery; Florence Gaven; Lucie Pellissier; Eric Reiter; Sylvie Claeysen; Joël Bockaert; Aline Dumuis
Journal:  Mol Biol Cell       Date:  2007-03-21       Impact factor: 4.138

7.  Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis.

Authors:  Martina Kocan; Heng B See; Natália G Sampaio; Karin A Eidne; Brian J Feldman; Kevin D G Pfleger
Journal:  Mol Endocrinol       Date:  2009-01-29

8.  Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.

Authors:  Justine S Paradis; Stevenson Ly; Élodie Blondel-Tepaz; Jacob A Galan; Alexandre Beautrait; Mark G H Scott; Hervé Enslen; Stefano Marullo; Philippe P Roux; Michel Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

9.  Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling.

Authors:  Marilyne Labasque; Eric Reiter; Carine Becamel; Joël Bockaert; Philippe Marin
Journal:  Mol Biol Cell       Date:  2008-09-03       Impact factor: 4.138

Review 10.  Physiological and pharmacological implications of beta-arrestin regulation.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  Pharmacol Ther       Date:  2008-12-06       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.